All News

2070 articles, sorted by publication time.

Biotechnology · global

Clinical Trials’ AI Focus Is Shifting From Finding Drugs to Finding People and Building Trust

Applied Clinical Trials Online’s latest ACT Brief places multimodal systems, trust-centered participant recruitment, and Big Pharma’s AI transformation on the same map. It is a reminder to the industry that the key to bringing AI into biomedical R&D is not only how powerful the models are, but whether they can be validated, understood, and used responsibly in real clinical workflows.

Biotech · global

OpenDDE Preprint Releases Open-Source All-Atom Model, Moving Drug AI Toward a Testable Structural Foundation

Aureka AI has released the code, weights, and evaluation workflow for its co-folding model together, so molecular structure reasoning in drug discovery no longer remains confined to closed systems; but this is still an early preprint result, and there remains a path of validation before it can truly screen drugs, estimate affinity, or design therapies.

Biopharma · global

Glioblastoma Pipeline Heats Up as Refractory Brain Cancer Pushes Drug Development Into a More Demanding Trial

The signal that more than 200 pharmaceutical companies are investing in R&D shows that glioblastoma remains one of the most urgent and hardest-to-break areas in oncology; the real question is not only how many drug candidates are on the way, but which strategies can pass through the many barriers of the blood-brain barrier, tumor heterogeneity, and clinical validation.